The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes
The impact of circulating total homocysteine levels on long-term cardiovascular mortality in patients with acute coronary syndromes
复制标题
DOI:
10.1016/j.ijcard.2007.02.011
复制
发表时间:
2008-03-14
影响因子:
3.5
通讯作者:
Argyrakis, Spyros K.
中科院分区:
文献类型:
--
作者:
Foussas, Stefanos G.;Zairis, Michael N.;Argyrakis, Spyros K.
Background: To evaluate the possible independent impact of circulating total homocysteine (tHcy) levels on long-term cardiovascular mortality, in patients with either ST-segment elevation myocardial infarction (STEMI), or non-ST-segment elevation acute coronary syndromes (NSTE-ACS).Methods: A total of 458 STEMI and 476 NSTE-ACS patients who presented consecutively, within the first 12 and 24 h of index pain respectively were studied. Each cohort was divided according to tertiles of circulating tHcy levels upon presentation. Early (30 days) and late (31 days through 5 years) cardiovascular mortality was the predefined study endpoint.Results: There was no difference in the risk of 30-day cardiovascular death among the tertiles of tHcy in patients with STEMI (7.2%, 8.5% and 12.4% for the first, second and third tertiles respectively; P-trend=0.3) or NSTE-ACS (3.1%, 3.8% and 5.7% for the first, second and third tertiles respectively; P-trend=0.5). Patients in the upper tHcy tertile were at significantly higher unadjusted risk of late (from 31 days trough 5 years) cardiovascular death than those in the other two tertiles in STEMI (23.4%, 27.9% and 41.8% for the first, second and third tertiles respectively; P-trend